1nHealth, a digital patient recruitment company accelerating enrollment for clinical trials all over the world, is excited to announce the appointment of Kayt Leonard as the company’s first Chief Commercial Officer (CCO). In this role, Leonard will oversee the company’s commercial strategy, spearheading initiatives to enhance client partnerships, expand market presence, and accelerate business growth in the rapidly evolving clinical research industry.
Clinical research organizations face immense pressure to bring life-saving therapies to market quickly, safely, and efficiently. But 80% of clinical trials fail to meet enrollment deadlines. Traditional patient recruitment methods are not enough when it comes to clinical trial enrollment.
With 1nHealth’s digital, patient-first approach, combined with advanced analytics, artificial
intelligence, and machine learning, the recruitment landscape is progressing radically.
“Effective patient recruitment requires forward-thinking and flexibility in an ever-changing
industry,” said Dan Brenner, CEO of 1nHealth. “Kayt brings a wealth of experience and a
proven track record of success in expanding and deepening partnerships with clients. Her
leadership will be invaluable as we continue to expand 1nHealth’s impact and enhance our
ability to deliver exceptional results for our clients.”
Leonard joins 1nHealth at a pivotal time as the company looks to scale operations through the release of 1nData, its all-in-one centralized study data hub that allows for patient tracking across multiple sites, instantaneous follow-up patient communication for site staff, and a customizable data dashboard tailored to each study’s needs that enables sponsors to view key metrics and site performance in real time. In a Q3 2024 survey, 1nData achieved class-leading metrics from users at site and sponsor organizations when compared to incumbent enrollment platform solutions. With Leonard joining as CCO, the company is poised to deepen its relationships with partners across Sponsor, CRO, and Research Site stakeholders, as well as scale its operations to meet the growing needs of the global clinical trials market.
“Across the globe, organizations are focused on bringing life-saving therapies to market faster and more safely, yet patient enrollment remains as the industry’s most significant bottleneck,” said Leonard. “Every patient deserves access to care, and every organization needs partners who move with urgency to deliver on that mission. 1nHealth has built a reputation as a premier, trusted leader in patient recruitment. Now with the official launch of 1nData, the opportunity to positively impact clinical trials at scale is accessible to Sponsors and CROs for the benefit of the patients they serve. I’m excited to join a team that’s driving impactful change for our clients, partners, and patients around the world.”
Prior to 1nHealth, Leonard held strategic leadership roles across the industry, working with
payers, providers, physicians, and pharmaceutical organizations. In her most recent role, she led the market strategy and engagement directives of the Health and Life Sciences practice at SAS, a global AI and analytics organization supporting pharma and healthcare companies around the world. Leonard’s research in health equity, disparities, and global health care access has been recognized by the World Health Organization, the Centers for Disease Control, the Food and Drug Administration, and the European Medicines Agency.
The need for effective patient recruitment in clinical trials has only been increasing in recent years as the industry faces growing complexity and increased competition for participants. Nearly 80% of clinical trials fail to meet enrollment deadlines. This bottleneck not only delays the delivery of life-saving treatments but also increases costs for Sponsors. Research studies’ enrollment criteria are continuously becoming more tailored as therapies become more targeted. The push for an increase in the sophistication and effectiveness of recruitment solutions is an industry imperative.
About 1nHealth
1nHealth is dedicated to revolutionizing patient recruitment for clinical trials. With over 30,000 patients enrolled across more than 100 studies, 1nHealth helps study sponsors and clinical research organizations overcome enrollment challenges, connect diverse patient populations to clinical studies, and improve trial outcomes. More than 700 research sites use 1nData’s cutting-edge enrollment tracking and communication technology, allowing them to connect quickly with patients, access real-time study data, and make well-informed decisions at every level. 1nHealth’s commitment to accelerating enrollment with the patient at the center ensures that every trial supported is positioned for success and advances human health.
